MAGI3 and cancer: The molecular mechanism underlying cancer-associated, intronic premature polyadenylation of MAGI3 has remained unknown because no cis-acting genetic mutations were found in the gene, making it unclear how pPA of MAGI3 can specifically be activated in one intron but not in other introns that also harbor cryptic PAS4.